News for Mergers & Acquisitions
Tuesday, June 11, 2013
AstraZeneca moves to buy respiratory drug specialist Pearl
Pearl Therapeutics is set to be acquired by drugs giant AstraZeneca for around $1.15 billion.
Monday, June 10, 2013
Centrica enters into talks for UK fracking stake
Energy giants Centrica who are the owners of British Gas, have entered into talks with Cuadrilla Resources, a leader in shale gas fracking within the UK, about buying a stake in shale gas operations.
Wednesday, June 05, 2013
Salesforce acquires Exact Target for $2.5 billion
Database giant Salesforce has moved to acquire digital marketing provider Exact Target, in a deal which is expected to be finalised by the end of July and worth $2.5 billion.
Dell and Oracle extend existing shared partnership
IT giants Dell and Oracle have extended an existing partnership, which will see Dell continue to package Oracle software and services with hardware, while Oracle in turn will optimise services for Dell’s product offering.
Friday, May 31, 2013
RBS rejects U.S. bid
The Royal Bank of Scotland has rejected a bid from a joint proposal from U.S. equity firms JC Flowers and Apollo as the bank begins to narrow the bidding shortlist.
Thursday, May 30, 2013
Chinese meat processor company buy U.S. pork giant
Chinese based meat processor Shuanghui International Holdings has signed off on the $4.7 billion purchase of U.S. company Smithfield Foods, the largest pork producer in the world.
Wednesday, May 29, 2013
AstraZeneca moves to acquire heart drug specialist
Pharmaceutical giant AstraZeneca has moved to acquire cardiovascular drug specialists Omthera Pharmaceuticals, in a deal valued at £294 million.
Tuesday, May 28, 2013
Waitrose moves to overseas markets
UK based food retailer Waitrose has signed a deal with Chilean supermarket chain Unimarc, as the UK chain continues to expand into overseas markets.
Severn Trent looks to renegotiated offer
Water company Severn Trent are expecting to receive a new increased takeover offer from a group of international investors, after the rejection of an offer £21 per share.